PAK4 and endometrial cancer: Furthermore, we have observed a nuclear localization of Pak4, especially the activated, phosphorylated Pak4 form (p-Pak4ser474) in endometrial cancer tissues [21], suggesting that Pak4 might activate ERα and contribute to estrogen-induced EC pathogenesis.